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Abstract
In the USA, the COVID-19 pandemic has created challenges beyond the direct consequences of the infection. Because of
shifting resources in response to need, many domains within the healthcare sector unrelated to COVID-19 have had interrupted abilities to provide care. In the current study, we focus on preventative sexual health care during the pandemic. In a
sample of 511 (mean age = 27.7) people, we examined quantitative data regarding continuation and discontinuation of birth
control and PrEP during the pandemic, along with qualitative data illustrating the underlying reasons for participants’ (dis)
continuation. Results showed that most (92.5%) of birth control users reported continuation of their birth control, with the
predominant reasons reported being use for health reasons, long-acting reversible contraceptive use, access to remote healthcare services, and increased vigilance over pregnancy prevention. Conversely, around half (52.6%) of PrEP-using participants
reported already discontinuing or planning to discontinue their PrEP regimen. Temporary abstinence and concerns about
accessing in-person health care were the predominant reasons for PrEP discontinuation. These results have implications for
both researchers and sexual healthcare providers. Disruptions to preventative sexual health care should be considered in
ongoing research about patient needs, and healthcare providers may wish to consider particular challenges faced by PrEP
users concerning re-start and continuation.
Keywords PrEP · Birth control · COVID-19 · Preventative sexual health care
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COVID-19 has posed a myriad of indirect challenges for individuals’ health and well-being including social isolation, job
loss, and financial insecurity. In addition to these challenges,
the pandemic brought new obstacles to receiving care for health
concerns unrelated to COVID-19 as it began to take a toll on
healthcare systems. Critical resources (e.g., respirators) were
reassigned from other medical units to COVID-19 wards, the
majority of non-critical medical procedures were canceled, and
the ability to access routine care and care for non-COVID-19
emergencies was vastly reduced (American Hospital Association [AHA], 2020). Despite many patients seeking urgent care
related to COVID-19 in March and April of 2020, hospital emergency rooms experienced a 42% drop in weekly visitors from
the previous year (Ornstein, 2020), demonstrating a reduction in
healthcare utilization typically needed for reasons unrelated to
COVID-19. This suggests that nearly half of those with healthcare needs that would otherwise prompt them to seek critical,
time-sensitive care did not do so. This shift may have been due
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to patients’ assumptions that they would not receive help from an
overburdened medical center, or to fear that they would expose
themselves to the COVID-19 virus in the process of seeking care
(Ornstein, 2020).
Taken together, these challenges may have affected access and
decision making for various areas of routine health care. One area
likely to have unique and substantial challenges is preventative
sexual health care. Preventative sexual health care aims to prevent
unintended pregnancies and sexually transmitted infections. The
Centers for Disease Control and Prevention reported that in the
USA, 12.6% of 72.2 million cisgender women aged 15–49 years
were prescribed the hormonal birth control pill between 2015
and 2017. This means an estimated 9 million women could have
needed these services during the 2020 COVID-19 pandemic
(Centers for Disease Control & Prevention, 2019). Additionally,
approximately 225,000 Americans were actively taking preexposure prophylaxis (PrEP) in the years prior to the pandemic
to protect themselves against HIV (Pebody, 2018). Thus, a sizable portion of the American population may have experienced
disruptions to these important forms of preventative sexual health
care. Although birth control and PrEP are only two forms of
potential sexual healthcare needs that could arise during the
COVID-19 pandemic, the consequences of discontinuing birth
control or PrEP can be long-lasting and life-altering. In the current study, we investigate the discontinuation of birth control
and PrEP, including reported reasons for such discontinuation
as well as the predictors of needing access to these medications
during the pandemic.

Potential Implications of COVID‑19 for Birth Control
Use
In the USA, birth control is widely used by individuals assigned
female at birth (Kanj et al., 2019; Mosher & Jones, 2010). More
than 99% of cisgender women in the USA aged 15–44 who have
ever had sexual intercourse have used at least one contraceptive
method (Mosher & Jones, 2010). Among contraceptive users,
25.3% use oral contraceptives, 21.8% rely on tubal sterilization,
11.8% use intrauterine devices (IUDs), 3.9% use injectables, 2.6%
use implants, and 2.4% use vaginal rings (Guttmacher, 2020). In
the current study, these methods are collectively referred to as
“birth control.” Although condoms are also a commonly used
contraceptive method, the present investigation focuses on birth
control that requires engagement with the healthcare system
and is thus more likely to be impacted by COVID-19-related
disruptions.
While oral contraceptives and tubal sterilization have been
the two most common birth control methods since 1982 (Guttmacher, 2020), the use of long-acting reversible contraceptives
(LARCs) such as IUDs and implants has become increasingly
more common, rising from 6% of contraceptive users in 2008 to
14% in 2014 (Kavanaugh & Jerman, 2018). In addition to pregnancy prevention, birth control is prescribed to treat numerous
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reproductive health concerns such as endometriosis (Grandi
et al., 2019), polycystic ovary syndrome (Mendoza et al., 2014),
premenstrual syndrome, and premenstrual dysphoric disorder
(Lete & Lapuente, 2016).
Despite the prevalence of birth control use, barriers to access
still exist. Nearly all birth control methods require a prescription,
which presents an obstacle for those who do not have insurance,
access to a doctor or clinic, time to devote to an appointment, and/
or the financial resources to pay for an appointment (Zuniga et al.,
2019). Transportation barriers and a lack of nearby pharmacies
may also impede birth control access (Lin & Lee, 2015). While
online telemedicine platforms are a viable alternative, they differ
in the birth control methods they provide, and the age-groups,
insurance providers, and geographic locations they serve (Zuniga
et al., 2019).
These existing barriers were likely exacerbated by the onset of
the COVID-19 pandemic through increased difficulty accessing
non-critical medical care (AHA, American Hospital Association, 2020), loss of income, and loss of employer-based health
insurance (Barry et al., 2020). While individuals with previously
inserted LARCs were likely less affected by COVID-19-related
interruptions in care, those whose devices were expiring and
those seeking a new prescription of continuing birth control pill
use may have faced increasingly steep obstacles to accessing
sexual health services. These barriers may have also affected
those seeking other forms of preventative sexual health care, such
as PrEP.

Potential Implications of COVID‑19 for PrEP Use
PrEP is an effective biomedical HIV prevention strategy that has
been increasingly utilized since it was approved by the FDA in
2012 (Food & Drug Administration [FDA], 2014). Despite the
increasing availability of PrEP, many barriers limit PrEP use,
particularly for marginalized communities. Commonly cited
barriers to PrEP use include logistical barriers such as cost and
health insurance coverage (Patel et al., 2017) as well as sociocultural barriers such as stigma associated with PrEP use (e.g.,
Dubov et al., 2018; Golub et al., 2019). Even when individuals
overcome barriers to PrEP uptake, they may face challenges to
continued PrEP adherence. For example, due to PrEP clinical
guidelines that recommend quarterly STI/HIV testing (Centers
for Disease Control & Prevention, 2017), PrEP use can require
frequent interaction with the healthcare system and regular blood
draws. While these protocols were determined with the goal of
preventing medical complications, these monitoring requirements can serve as gatekeepers, limiting PrEP use to those who
can regularly access and attend health care (Siegler et al., 2019).
Because PrEP is a biomedical HIV prevention medication,
many understand PrEP as being relevant solely for individuals
who engage in health behaviors that put one at increased risk
for HIV, including having multiple sexual partners, intravenous
drug use, and/or engaging in condomless penetrative sex, with
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a particular focus on anal sex. The largest proportion of PrEP
users in the USA are men who have sex with men (MSM); this
community also disproportionately holds the burden of HIV
prevalence (Elion et al., 2019). Beyond this focus on epidemiological risk, many use PrEP for additional benefits beyond HIV
prevention such as personal psychological benefits (Allen et al.,
2020; Price, English, & Golub, 2020; Whitfield et al., 2019) and
reduced anxiety in the context of HIV serodiscordant partnerships (Carlo Hojilla et al., 2016). There are multiple ways that
individuals take HIV-prevention medications, including taking
post-exposure prophylaxis (PEP) after a potential exposure and
taking event-driven PrEP planned around a potential exposure.
While most PrEP users take the pill daily, event-driven PrEP
involves taking two pills in the 24 h before an anticipated potential HIV exposure (e.g., sexual encounter), and then, one pill each
day for two days after the potential exposure (often called 2-1-1
PrEP). This method is often preferred when individuals are able
to anticipate sexual encounters (Reyniers et al., 2018), which may
be more common during COVID-19 when many may be making
more intentional decisions about intimate contact. Ultimately,
PrEP use decisions may be reliant on healthcare access, sexual
behavior, and psychological factors, all of which have likely been
impacted by COVID-19.
To date, little is known about the ways that the ongoing COVID-19 pandemic has influenced PrEP use. What we
do know, however, is that many individuals are continuing to
engage in sexual behavior that could transmit HIV (Lehmiller
et al., 2021; Stephenson et al., 2020) illustrating the continuing
need for access to PrEP. Limited existing research on PrEP and
COVID-19 suggests that the majority of PrEP users are maintaining PrEP use (Fernandes et al., 2020; Pampati et al., 2020).
Ultimately, the existing studies about HIV risk behavior, PrEP,
and COVID-19 suggest that understanding PrEP use patterns
during the pandemic is crucial for understanding the health and
well-being of PrEP users.
COVID-19 has likely interrupted preventative sexual health
care for both birth control and PrEP in some similar ways; however, there are key differences to note. While HIV risk is assumed
to increase with the number of sexual partners (Centers for Disease Control & Prevention, 2017), pregnancy risk is conveyed by
each instance of intercourse, irrespective of the number of unique
partners. A couple who does not use any contraceptive method
for vaginal intercourse has an 85% chance of becoming pregnant
within one year (Guttmacher, 2020). Therefore, stay-at-home
orders and quarantine procedures impact pregnancy risk and HIV
risk—and birth control and PrEP use, respectively—differently.
Further, stigmatization and required interaction with the healthcare system differ for these two preventative medications. Exploring birth control and PrEP side by side provides a case study for
understanding factors that impact one’s ability and decision to
continue or discontinue preventative sexual healthcare services
during the COVID-19 pandemic.
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Present Study
In the present exploratory study, we examined changes to the utilization of birth control and PrEP during the onset of the COVID19 pandemic in the USA, between April and June 2020. Specifically, the present study aimed to address the following questions:
(1) How common was the discontinuation of birth control or
PrEP during the first months of the COVID-19 pandemic in the
USA? (2) What was the relationship between sexual behavior
and rates of (dis)continuation? (3) What reasons did people selfreport for their birth control or PrEP (dis)continuation?

Method
Participants
Participants were 235 men, 217 women, 44 non-binary individuals, and 8 who identified as something else or skipped the gender item (N = 511). Nine percent of the full sample identified as
transgender (n = 48). Mean age was 27.73 years. The sample was
majority white (72%) with the next largest groups identifying as
Black/African American (12%) and Multiracial (11%). Twentyone percent of the sample was Latinx. Regarding sexual orientation, 40% identified as heterosexual, 18% identified as bisexual,
17% identified as gay or lesbian, 12% identified as queer, 7%
identified as pansexual, 3% identified as asexual, 2% reported
another identity, and 3% said they were not sure. Full participant
demographics are presented in Table 1.
At the time of data collection, April through June 2020, the
USA was experiencing the first major wave of the COVID-19
pandemic. Many areas of the country had instituted policies
aimed at limiting COVID-19 transmission. Via a checklist item,
all participants indicated that nonessential travel has been banned
or discouraged in their local area, and 91.4% indicated that large
public gatherings had been banned or were limited in size; 80.8%
reported that nonessential businesses were closed, including bars,
restaurants, gyms, and other social gathering spots. While we did
not ask specifically about whether doctor’s offices were open,
these statistics indicate that most participants were experiencing
limitations on their ability to travel, gather, and access public
spaces.

Procedure
Participants were recruited via social media posts advertising the
study and via an email list from prior studies conducted by the
Hunter Alliance for Research and Translation (HART) on sexual
health containing participants who had consented to be contacted
again for future research purposes. Eligibility criteria were being
18 years or older, being fluent in English, and living in the USA.
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Table 1  Participant Demographics (N = 511)

Age

Racea

n or M

% or SD

27.73

9.13

White

369

Native American or Alaska Native

8

72.21%
1.57%

East Asian

24

4.70%

West Asian

6

1.17%

Black/African American

59

11.55%

Native Hawaiian or other Pacific Islander

6

1.17%

Multiracial

57

11.15%

Other

28

5.48%

Latinx (n = 488)

109

22.34%

54

11.82%

Income (n = 457)
< $20,000
$20,000–$55,000

101

22.10%

$55,000–$100,000

134

29.32%

$100,000 +

119

26.04%

Don’t know/prefer not to answer

49

10.72%

Education (n = 459)
Less than BA

169

36.82%

BA

129

28.10%

More than BA

156

33.99%

Other

5

1.09%

Gender identity (n = 504)
Man

235

46.63%

Woman

217

43.06%

Non-binary

44

8.73%

Agender

3

0.60%

Do not know

3

0.60%

Another gender identity not listed

1

0.20%

Choose not to answer

1

0.20%

Transgender (n = 508)

48

9.45%

Sexual orientation (n = 510)
Asexual

13

2.55%

Bisexual

91

17.84%

Gay or lesbian

84

16.47%

Heterosexual

202

39.61%

Pansexual

35

6.86%

Queer

60

11.76%

I’m not sure

14

2.75%

Another identity not listed

11

2.16%

Relationship status (n = 510)
Single

248

48.63%

One or more serious relationships

251

49.22%

Other

11

2.16%

115

23.09%

Region (n = 498)
West
Midwest

58

11.65%

South

182

36.55%

Northeast

140

28.11%

Pacific

4

a

0.80%

Participants were able to select all of the race and ethnicity categories presented. The total percentages equal greater than 100% because
many participants selected more than one category
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The survey was conducted fully online using the RedCap
platform and was self-paced. Participants completed the surveys between April and June of 2020, which was 1–3 months
after the World Health Organization declared COVID-19 a
global pandemic in March 2020 (Chappell, 2020). In addition to
providing demographic information, participants responded to
a variety of measures regarding their sexual healthcare utilization and COVID-19 prevention behaviors during the onset of the
COVID-19 pandemic. Participants could skip any items they did
not wish to answer, which is reflected in fluctuating sample sizes
in the analyses. Compensation was given in the form of 17 raffled
virtual gift cards for $40 USD.

Measures
These data were taken from a larger survey on multifaceted health
outcomes during the COVID-19 pandemic in the USA. Here we
only include measures relevant to the current study. Note that
the survey explicitly stated for participants that the COVID-19
pandemic began in the USA around March 2020.
Birth Control Use and Continuation
Participants reported whether or not they were using birth
control by responding to the question, “Are you currently
using contraception/birth control methods other than condoms (i.e., birth control pills, IUD, etc.)?” If participants
indicated birth control use, they were asked whether they
were using an IUD, hormonal pills, injection, or implant.
Current users were then asked, “You indicated you were taking contraception/birth control. Do you have plans to discontinue your prescription during lockdown?” to assess (dis)continuation. Individuals who indicated plans for stopping birth
control use were categorized as birth control discontinuers.
Individuals who did not report intentions to stop using birth
control were categorized as birth control continuers. Note
that we did not define “lockdown” for participants. However, “lockdown” was common terminology around the world
at the time of data collection, encompassing stay-at-home
orders, nonessential businesses closing, quarantining, and
curfews (Perra, 2021).
PrEP Use and Continuation
Participants were asked about PrEP use using the question,
“Are you currently using PrEP for biomedical prevention
against HIV?” with dichotomous yes/no response options.
Additionally, to capture individuals who had already stopped
PrEP prior to the survey, all participants were asked, “Were
you using PrEP before the pandemic started but stopped due
to lockdown orders?” Participants who indicated that they
were currently using PrEP were asked, “You indicated you
were taking PrEP. Do you have plans to discontinue your
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prescription during lockdown?” Individuals who either indicated stopping PrEP use due to the pandemic or indicated
plans to discontinue during lockdown were categorized as
PrEP discontinuers. Individuals currently taking PrEP who
did not have plans to discontinue during lockdown were categorized as PrEP continuers.
Reasons for (Dis)continuation
Individuals who indicated using PrEP or birth control were
asked open-ended questions about whether their approaches
had changed. The questions read, “Since the beginning of the
COVID-19 Coronavirus pandemic, have you changed your
approach to contraceptives or birth control (pre-exposure
prophylaxis (PrEP for HIV prevention))?”.
Sexual Behavior During the Pandemic
Participants responded to dichotomous yes/no questions
about their sexual activity during and before the pandemic.
They reported whether they had engaged in any partnered
sexual activity since the beginning of the COVID-19 pandemic in the USA (since March 2020), as well as within the
last two weeks. They also reported intentions to engage in
partnered sexual activity in the next two weeks and whether
they were currently having sex with someone outside their
household/lockdown pod. Additionally, participants reported
the number of partners with whom they engaged in sexual
activity in the last three months, the number of different types
of sex acts in the past 30 days (e.g., oral sex, anal sex, vaginal
sex), and the percentage of time they used condoms during intercourse in the last 30 days (sliding scale from 0% to
100%).
Likelihood of Needing Sexual Healthcare Services
Participants reported their likelihood of needing access to
different sexual healthcare services (i.e., contraceptives,
morning after pill/emergency contraception, and PrEP/PEP)
during lockdown on a 7-pt Likert scale from (1) very unlikely
to (7) very likely.

Sample and Quantitative Analysis
There were 744 individuals who consented to participate
in the survey. Of those who started the survey, 233 did not
complete the sections on birth control or PrEP, leaving a
final sample of 511. Because of the small number of birth
control discontinuers (n = 10) and a relatively small number
of PrEP users (n = 57), we did not have adequate power to
conduct inferential statistics to test whether demographic
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or behavioral factors predicted birth control or PrEP continuation. However, the consequences of discontinued preventative health care are wide-ranging and potentially quite
serious. As such, we proceed by presenting demographic
trends: comparisons between continuers and discontinuers,
and between the full sample and PrEP/birth control users. All
analyses were prepared using the Statistical Package for the
Social Sciences (SPSS 26.0).

Qualitative Analysis
We analyzed the open-text responses regarding changes participants have made to their PrEP or birth control use following a
thematic analysis approach (Braun & Clarke, 2006), with themes
being data-driven rather than theoretically driven. Three members of the research team developed a codebook of reasons for
PrEP continuation and discontinuation, and a codebook of reasons for birth control continuation and discontinuation. The two
co-first authors coded the responses independently and discussed
discrepancies to reach intercoder agreement. The main themes
from the coding are presented below.

Results
Quantitative Analysis
Birth Control Use and Discontinuation
Demographics and sexual behavior of birth control users, continuers, and discontinuers are presented in Table 2. About onequarter of the sample (n = 136; 26.7%) were birth control users,
meaning they responded “yes” to the question, “Are you currently
using contraception/birth control methods other than condoms
(i.e., birth control pills, IUD, etc.)?” Among birth control users,
the most common method of contraception was an IUD (44.1%),
followed by hormonal pills (41.9%) and implants (8.8%). Two
participants (1.5%) indicated using both IUDs and hormonal
pills, and one participant (0.7%) reported using injections. Four
participants (2.9%) indicated current birth control use but did
not respond to the question about specific type. Two of these
participants later indicated the use of permanent birth control
methods (tubal sterilization and vasectomy), while the other two
declined to provide additional information.
The individuals using birth control had a similar demographic
breakdown to the overall sample. A higher percentage of birth
control users had a college degree or higher (44.6%), were heterosexual (44.4%), and were in a serious relationship (76.3%),
relative to the full sample.
Compared to nonusers, descriptive trends suggest that birth
control users differed in their sexual behavior, with birth control users more sexually active than nonusers (see Table 3 for
full sample sexual behavior). More birth control users reported
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Table 2  Descriptive characteristics of birth control users, continuers, and discontinuers

Age
Racea
White
Native American or Alaska Native
East Asian
West Asian
Black/African-American
Native Hawaiian or other Pacific Islander
Multiracial
Other
Latinx (n = 130)
Income (n = 130)
< $20,000
$20,000-$55,000
$55,000-$100,000
$100,000 +
Don’t know/prefer not to answer
Education (n = 130)
Less than BA
BA
More than BA
Other
Gender identity
Man
Woman
Non-binary
Agender
Transgender
Sexual orientation (n = 135)
Asexual
Bisexual
Gay or lesbian
Heterosexual
Pansexual
Queer
I’m notsure
Another identity not listed
Relationship status (n = 135)
Single
One or more serious relationships
Other
Region (n = 135)
West
Midwest
South
Northeast
Pacific

13

Birth control User
(n = 136)

Continuer (n = 124)

Discontinuer
(n = 10)

n or M

% or SD

n or M

% or SD

n or M

% or SD

27.47

6.55

27.72

6.69

25.3

4.06

107
4
6
2
13
1
13
4
28

78.68
2.94
4.41
1.47
9.56
0.74
9.56
2.94
21.54

100
3
4
2
10
1
12
4
25

80.65
2.42
3.23
1.61
8.06
0.81
9.68
3.23
21.19

6
1
2
0
2
0
1
0
2

60.00
10.00
20.00
0.00
20.00
0.00
10.00
0.00
20.00

13
24
44
39
10

10.00
18.46
33.85
30.00
7.69

13
20
42
38
6

10.92
16.81
35.29
31.93
5.04

0
4
2
1
3

0.00
40.00
20.00
10.00
30.00

30
41
58
1

23.08
31.54
44.62
0.77

28
36
54
1

23.53
30.25
45.38
0.84

1
5
4
0

10.00
50.00
40.00
0.00

23
97
13
3
13

16.91
71.32
9.56
2.21
9.56

23
85
13
3
13

18.55
68.55
10.48
2.42
10.48

0
10
0
0
0

0.00
100.00
0.00
0.00
0.00

3
34
4
60
12
17
3
2

2.22
25.19
2.96
44.44
8.89
12.59
2.22
1.48

2
32
4
56
10
16
2
2

1.61
25.81
3.23
45.16
8.06
12.90
1.61
1.61

0
1
0
4
2
1
1
0

0.00
11.11
0.00
44.44
22.22
11.11
11.11
0.00

32
103
0

23.70
76.30
0.00

26
97

20.97
78.23
0.00

5
5

50.00
50.00
0.00

35
16
48
36
0

25.93
11.85
35.56
26.67
0.00

33
15
42
34

26.61
12.10
33.87
27.42
0.00

1
1
5
2

11.11
11.11
55.56
22.22
0.00
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Table 2  (continued)

Sexual behavior
Currently having sex with anyone outside of household/isolation pod
Oral sex in the past 12 months
Penetrative intercourse (either anal or vaginal) in the last 12 months
Engaged in any partnered activity since the beginning of the pandemic
Engaged in any partnered activity in the past two weeks
Planning on engaging in partnered sexual activity in the next two weeks
Number of sex partners last 3 months
Number oftimes gave oral sex in past 30 days
Number of times received oral sex in past 30 days
Number of times had vaginal sex in past 30 days
Number of times had anal sex in past 30 days
Percentage of time used a condom during intercourse in past 30 days
Likelihood of needing access to PrEP/PEP during lockdownb
Likelihood of needing access to contraceptives during lockdownb
Likelihood of needing access to morning after pill/emergency contraception during lockdownb

Birth control User
(n = 136)

Continuer (n = 124)

Discontinuer
(n = 10)

n or M

% or SD

n or M

% or SD

n or M

% or SD

17
121
122
93
79
84
1.21
4.39
3.89
6.74
0.50
16.11
1.37
3.51
1.56

12.50
88.97%
89.71%
69.40%
58.96%
62.69%
1.06
5.37
7.19
8.14
1.47
33.51
1.27
2.78
1.36

16
112
113
87
74
78
1.22
4.31
3.76
6.81
0.54
16.73
1.41
3.58
1.59

12.90%
90.32%
91.13%
70.73%
60.16%
63.41%
1.09
5.3
7.17
8.29
1.53
34.26
1.32
2.79
1.39

1
9
9
6
5
6
1
5.44
5.44
5.89
0
5.17
1
3
1.3

10.00%
90.00%
90.00%
60.00%
50.00%
60.00%
0.54
6.41
7.7
6.39
0
12.17
0
2.83
0.95

a

Participants were able to select all of the race and ethnicity categories presented. The total percentages equal greater than 100% because many
participants selected more than one category. bLikelihood of needing sexual healthcare services rated on a 7-point Likert scale (1 = very unlikely,
7 = very likely)

having penetrative intercourse in the last 12 months (n = 121;
88.9%), compared to individuals who were not using birth control (n = 213; 57.6%). Birth control users were more likely to
have engaged in sexual activities in the past two weeks and were
more likely to report that they were planning on engaging in
partnered sexual activity in the next two weeks. Birth control
users, however, were no more likely to report having sex with
anyone outside their household/lockdown pod than nonusers,
possibly reflecting that a substantial proportion of birth control
users (n = 68; 50.0%) lived with a relationship partner.
Of birth control users, only 10 people (7.5%) indicated plans
to discontinue their birth control prescription during the lockdown. Thus, the majority of birth control users were continuers
(n = 124, 92.5%), and we were not able to make inferential statistical demographic and behavioral comparisons between birth
control continuers and discontinuers. A substantial portion of
birth control users reported using long-acting reversible contraceptives (LARC)—with 47.0% using an IUD (n = 62) and 9.1%
using an implant device (n = 12)—rendering a large amount of
the sample unlikely to be discontinuing during the pandemic.
Remaining birth control users were either using hormonal pills
(n = 57; 43.2%) or injection (n = 1; 0.8%).
PrEP Use and Discontinuation
Demographics and sexual behavior of the PrEP users, PrEP continuers, and PrEP discontinuers are found in Table 4, along with

sexual behavior information. Fifty-seven (11.2%) participants
were PrEP users (i.e., either on PrEP at the time of the survey or
had recently stopped due to COVID-19). The individuals taking PrEP had a similar demographic breakdown to the overall
sample. There were some differences, however, with a higher
percentage of PrEP users having higher education and higher
income than those in the sample who were not PrEP users. Most
individuals on PrEP identified with a sexual minority identity
(n = 54; 94.7%).
Compared to nonusers, descriptive trends suggest that PrEP
users engaged in more sexual behavior, which is consistent with
PrEP often being recommended to those with high levels of epidemiological risk for HIV (Centers for Disease Control & Prevention, 2017). About half of PrEP users (n = 27; 47.3%) planned
to continue their PrEP use during the pandemic (PrEP continuers)
and the other half (n = 30; 52.6%) had either discontinued PrEP
due to the pandemic or had plans to discontinue due to the pandemic (PrEP discontinuers). Demographic patterns of continuers
were similar to discontinuers.
There were some differences between PrEP continuers and
PrEP discontinuers in sexual behavior, with PrEP continuers
reporting more sexual activity on a variety of measures. Despite
reporting similar rates of oral sex and penetrative intercourse
in the past 12 months, PrEP continuers reported higher sexual
behavior at the time of the pandemic. PrEP continuers were more
likely to report engaging in partnered activity since the beginning of the COVID-19 pandemic (n = 21, 77.8%) compared to
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Table 3  Full sample sexual behavior

Currently having sex with anyone outside of household/isolation pod
Yes
No
Oral sex in the past 12 months
Yes
No
Penetrative intercourse (either anal or vaginal) in the last 12 months (n = 510)
Yes
No
Engaged in any partnered activity since the beginning of the pandemic (n = 502)
Yes
No
Engaged in any partnered activity in the past two weeks (n = 501)
Yes
No
Planning on engaging in partnered sexual activity in the next two weeks (n = 510)
Yes
No
Number of sex partners last 3 months (n = 379)
Number of times gave oral sex in past 30 days (n = 370)
Number of times received oral sex in past 30 days (n = 372)
Number of times had vaginal sex in past 30 days (n = 334)
Number of times had anal sex in past 30 days (n = 332)
Percentage of time used a condom during intercourse (vaginal or anal) in past 30 days (0–100%) (n = 289)
Likelihood of needing access to PrEP/PEP during lockdown (n = 492)a
Likelihood of needing access to contraceptives during lockdown (n = 490)a
Likelihood of needing access to morning after pill/emergency contraception during lockdown (n = 488)a
a

n or M

% or SD

64
447

12.52
87.48

377
134

73.78
26.22

340
170

66.67
33.33

254
248

50.60
49.40

187
314

37.33
62.67

212
288
1.67
3.12
2.98
4.26
1.06
23.60
1.59
2.20
1.40

42.40
57.60
2.78
4.97
6.04
7.36
3.61
39.10
1.56
2.14
1.05

Likelihood of needing sexual healthcare services rated on a 7-point Likert scale (1 = very unlikely, 7 = very likely)

PrEP discontinuers (n = 16; 53.3%). Additionally, about half of
the PrEP continuers (n = 14; 51.9%) reported currently having
sex with someone outside of their household/lockdown pod compared to a small number of PrEP discontinuers (n = 3; 10.0%). A
higher percentage of PrEP continuers reported having sex in the
past two weeks (n = 18; 66.7%) compared to PrEP discontinuers (n = 9; 30.0%) and a higher percentage of PrEP continuers
reported planning to engage in partnered sexual activity in the
next two weeks (n = 19; 70.4%) compared to PrEP discontinuers
(n = 10; 33.3%). In addition to examining dichotomous variables
describing whether or not participants engaged in sexual behavior, we asked about the frequencies of certain sexual behaviors.
Comparing the means of PrEP continuers and PrEP discontinuers
on sexual behavior frequency variables revealed similar trends
with PrEP continuers engaging in higher numbers of sex acts
and reporting a higher number of sexual partners (see Table 4).
The percentage of condom use during intercourse in the past
30 days was approximately the same with PrEP continuers
using condoms 10.0% of the time on average (SD = 24.9) and
PrEP discontinuers using condoms 8.1% of the time on average

13

(SD = 17.6). Consistent with PrEP use decisions, PrEP continuers reported a higher likelihood of needing access to PrEP/PEP
during lockdown on a 7-point Likert scale (PrEP continuers
M = 6.04, SD = 1.64; PrEP discontinuers M = 3.48, SD = 2.46).

Qualitative Analysis
What Reasons Do People Self‑Report for Their Birth Control
(Dis)continuation?
Of the 136 birth control users who were asked to provide qualitative descriptions of their birth control use or discontinuation
during the pandemic, 79.4% (n = 108) responded. Those who
responded were not demographically different from those who
skipped the question. Eighty-one percent (n = 88) of these
respondents reported that their birth control practices had not
changed. There were five major themes related to birth control use: no or low pregnancy risk, birth control used for health
reasons other than pregnancy prevention, LARC use, access to
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Table 4  Descriptive characteristics of PrEP users, continuers, and discontinuers

Age
Racea
White
Native American or Alaska Native
East Asian
West Asian
Black/African-American
Native Hawaiian or other Pacific Islander
Multiracial
Other
Latinx (n = 56)
Income (n = 52)
< $20,000
$20,000-$55,000
$55,000-$100,000
$100,000 +
Don’t know/prefer not to answer
Education (n = 52)
Less than BA
BA
More than BA
Other
Gender identity (n = 56)
Man
Woman
Non-binary
Another gender not listed
Transgender (n = 56)
Sexual orientation
Asexual
Bisexual
Gay or lesbian
Heterosexual
Pansexual
Queer
I’m not sure
Another identity not listed
Relationship status
Single
One or more serious relationships
Other
Region (n = 56)
West
Midwest
South
Northeast
Pacific

PrEP user (n = 57)

Continuer (n = 27)

Discontinuer
(n = 30)

n or M

% or SD

n or M

% or SD

n or M

35.23

8.65

35.15

9.82

35.3

% or SD
7.62

41
0
1
0
6
1
7
3
8

71.93%
0.00%
1.75%
0.00%
10.53%
1.75%
12.28%
5.26%
14.29%

19
0
0
0
3
1
3
1
3

70.37%
0.00%
0.00%
0.00%
11.11%
3.70%
11.11%
3.70%
11.11%

22
0
1
0
3
0
4
2
5

73.33%
0.00%
3.33%
0.00%
10.00%
0.00%
13.33%
6.67%
17.24%

9
9
15
19
0

17.31%
17.31%
28.85%
36.54%
0.00%

5
6
5
8

20.83%
25.00%
20.83%
33.33%
0.00%

4
3
10
11

14.29%
10.71%
35.71%
39.29%
0.00%

5
20
26
1

9.62%
38.46%
50.00%
1.92%

2
6
15
1

8.33%
25.00%
62.50%
4.17%

3
14
11
0

10.71%
50.00%
39.29%
0.00%

52
1
2
1
7

92.86%
1.79%
3.57%
1.79%
12.50%

27
0
0
0
3

100.00%
0.00%
0.00%
0.00%
11.11%

25
1
2
1
4

86.21%
3.45%
6.90%
3.45%
13.79%

0
2
42
3
1
7
0
2

0.00%
3.51%
73.68%
5.26%
1.75%
12.28%
0.00%
3.51%

0
2
20
0
1
4
0
0

0.00%
7.41%
74.07%
0.00%
3.70%
14.81%
0.00%
0.00%

0
0
22
3
0
3
0
2

0.00%
0.00%
73.33%
10.00%
0.00%
10.00%
0.00%
6.67%

31
19
7

54.39%
33.33%
12.28%

13
9
5

48.15%
33.33%
18.52%

18
10
2

60.00%
33.33%
6.67%

4
3
25
23
1

7.14%
5.36%
44.64%
41.07%
1.79%

1
1
13
11
1

3.70%
3.70%
48.15%
40.74%
3.70%

3
2
12
12
0

10.00%
6.67%
40.00%
40.00%
0.00%
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Table 4  (continued)

Sexual behavior
Currently having sex with anyone outside of household/isolation pod
Oral sex in the past 12 months
Penetrative intercourse in the last 12 months
Engaged in any partnered activity since the beginning of the pandemic
Engaged in any partnered activity in the past two weeks
Planning on engaging in partnered sexual activity in the next two weeks
Number of sex partners last 3 months
Number of times gave oral sex in past 30 days
Number of times received oral sex in past 30 days
Number of times had vaginal sex in past 30 days
Number of times had anal sex in past 30 days
Percentage of time used a condom during intercourse in past 30 days
Likelihood of needing access to PrEP/PEP during lockdown
Likelihood of needing access to contraceptives during lockdown
Likelihood of needing access to morning after pill/emergency contraception during lockdown

PrEP user (n = 57)

Continuer (n = 27)

Discontinuer
(n = 30)

n or M

% or SD

n or M

% or SD

n or M

% or SD

17
56
54
37
27
29
5.20
2.70
3.09
0.83
3.63
9.24
4.69
1.38
1.17

29.82%
98.25%
94.74%
64.91%
47.37%
50.88%
5.80
4.94
6.00
2.20
7.42
22.02
2.40
1.38
0.92

14
27
27
21
18
19
6.69
4.23
4.19
1
5.35
10
6.04
1.44
1.24

51.85%
100.00%
100.00%
77.78%
66.67%
70.37%
6.99
6.33
6.13
2.56
8.3
24.88
1.64
1.53
1.2

3
29
27
16
9
10
3.86
1.29
2.1
0.67
1.92
8.12
3.48
1.32
1.11

10.00%
96.67%
90.00%
53.33%
30.00%
33.33%
4.15
2.54
5.8
1.82
6.1
17.64
2.36
1.25
0.58

a

Participants were able to select all of the race and ethnicity categories presented. The total percentages equal greater than 100% because many
participants selected more than one category. bLikelihood of needing sexual healthcare services rated on a 7-point Likert scale (1 = very unlikely,
7 = very likely)

remote healthcare services for birth control, and increased vigilance over pregnancy prevention.
No or Low Pregnancy Risk Multiple participants agreed that
their birth control decisions were affected by their current
unintended pregnancy risk. Some cited temporary abstinence, including one participant who said, “…because I am
not sexually active [birth control] is pointless.” Other participants reported that their sexual activity did not put them
at risk for pregnancy; one participant said they “have been
sterilized since 1997” while another said, “I have an IUD
and I only have sex with vaginas.” These participants did
not change their contraception decisions as a result of the
pandemic because they were not concerned about unintended
pregnancy.

Most indicated no change in their use of these long-acting
methods such as IUDs and implants because, as one participant said, “…it doesn’t depend on daily adherence decisions.”
However, two participants expressed concerns about needing their IUDs replaced. Said one participant, “My IUD has
expired since quarantine. And I cannot get a new one during
this time. Additionally, I cannot take other forms of birth control while my IUD is in me, but cannot get it removed either.
My partner and I have been increasing in use of condoms.”

Birth Control for Health Reasons Beyond Pregnancy Pre‑
vention Several participants who reported continued birth
control said they used birth control for reasons unrelated to
pregnancy prevention, including “period pain” and “to control/balance my hormones, which have caused health issues.”
Conversely, other participants cited decreased pregnancy risk
during the pandemic as an opportunity to discontinue the pill
for mental and physical health reasons.

Access to Remote Healthcare Services While birth control
access was limited as a result of the pandemic, some participants had access to telehealth options. One participant said,
“With my healthcare, I get my birth control pills delivered,
so things will not change with the onset of the pandemic.”
Another participant reported starting birth control since the
onset of the pandemic. They said, “I actually went on birth
control in April 2020. I used planned parenthood’s telehealth
and the [Planned Parenthood Direct] app to order my [birth
control]. I wanted an IUD to stop my period completely but
I did not want to go to the clinic in person, so I’m using a pill
instead.” Compared to participants on PrEP, those on birth
control were less reliant on in-person medical services to
access medication.

Long‑Acting Reversible Contraceptives Several other participants also reported using long-acting birth control methods.

Increased Vigilance over Pregnancy Prevention Like the
participant who started birth control in April 2020, multiple
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participants expressed increased vigilance over pregnancy
prevention. One individual stated, “I have ZERO desire to
get pregnant and either seek an abortion or get prenatal care
during a pandemic.” Another participant shared a similar
sentiment, saying,
“Originally had stopped taking medications until a couple of months ago until a friend recently got pregnant
and had an abortion procedure done. I always use condoms but it still worried me so started back on Yaz and
soon switching to Xulane patch.”
This increased vigilance did not necessarily reflect
changes in sexual behavior but rather changes in participants’
motivation to avoid unintended pregnancy.
What Reasons Do People Self‑Report for their PrEP (Dis)
continuation?
Of the 57 PrEP users who were asked to provide qualitative
descriptions of their PrEP use or discontinuation during the
pandemic, 70.2% (n = 40) responded. These respondents were
not demographically different from participants who skipped
the question. Among the qualitative responses about participant
reasons for PrEP continuation and discontinuation (n = 40), four
major themes emerged. The predominant reason participants
gave for PrEP continuation was psychological well-being, and
the predominant reasons participants gave for PrEP discontinuation were temporary abstinence and concerns about accessing inperson health care. Participants also wanted to remain prepared
for post-pandemic sexual behavior, which motivated some to
continue daily PrEP and led others to temporarily discontinue
PrEP or switch to 2–1-1 event-driven PrEP use.
Psychological Well‑Being Psychological well-being was a
recurring theme among individuals who described a reason
for PrEP continuation. Specifically, multiple participants
indicated that their decision to continue PrEP was motivated
by the sense of security that comes with biomedical HIV
protection, including one participant with an HIV-positive
sexual partner:
“I am slightly less strict about adherence because…
the only person I’ve had sex with since early March is
HIV-positive, reports having had a consistently undetectable viral load for several years, and I do believe
he has an undetectable viral load and cannot transmit
HIV to me. However, even though he’s my only sexual
partner, I’m continuing PrEP anyway for the anxiety /
emotional benefit of not needing to depend on his medication adherence for my HIV prevention, even though
I trust that he’s adherent, and because whenever I do
start having sex with other people, the CDC says it’ll
take 20 days of daily dosing for me to regain maximal
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protection, and I may struggle to wait that long, so I’d
rather maintain maximal protection throughout the
pandemic.”
Temporary Abstinence Like the participants who cited
temporary abstinence as their reason for discontinuing birth
control, some PrEP users reported prior or upcoming PrEP
discontinuation due to changes in their sexual behavior during the pandemic. Some participants indicated they were
abstinent at the time of the survey, including one participant
who said they “…stopped taking PrEP while abstaining from
sex.” However, abstinence had not led all participants to discontinue, including one who said, “I still continue taking it
even though I haven’t had sex.” Other participants expressed
that they had been abstinent at the beginning of the pandemic,
but had taken steps to resume sexual activity. One participant
referenced “loosening” lockdown restrictions while another
cited mental health concerns, saying, “I stopped [PrEP] for a
month but started taking it again after I decided living alone,
working alone, and abstinence was damaging my mental
health.”
Remaining Prepared for Post‑Pandemic Other participants
similarly indicated a desire to be prepared for post-pandemic
sexual behavior. This was a reason cited for both participants
continuing daily PrEP and individuals temporarily discontinuing PrEP. One participant wrote, “While I don’t feel I really
need [PrEP] for protection at the moment, I don’t want to
loose (sic) the habit, and I want to be ready for the post-covid
era.” While this individual prepared for future PrEP need by
continuing to take daily PrEP, others reported preparing for
future need by saving their current supply or switching to
2–1-1 use. One participant said they “…stopped taking it to
stockpile” and another said, “…If I were to obtain a refill, I
would save any newly acquired PrEP medication for 2–1-1
use, in the unlikely event I would be having sex.” Two other
participants also reported shifts from daily PrEP to 2–1-1
event-driven PrEP.
Concerns about Accessing In‑Person Health Care Related to
concerns about PrEP supply were concerns about accessing
in-person health care. Said one participant, “My medication
has run out and I do not feel comfortable going out to pick up
a refill.” Another reported, “I am more worried about going
in person for bloodwork than continuing prep while in quarantine, so if I have to go physically to the lab for bloodwork,
then I will probably opt to go off the medication and resume
when it feels safe to go in person to the dr.” PrEP users had
access to fewer telehealth options than those seeking birth
control.
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Discussion
In the present study, we examined patterns of continuation and
discontinuation of birth control and PrEP during the COVID19 pandemic. The majority of people who used birth control
before the pandemic continued to do so. Participants reported
several factors related to continuation, including birth control use
for health reasons beyond pregnancy prevention, long-term use
options (i.e., LARCs), and increased vigilance over pregnancy
prevention during the pandemic. Comparatively, approximately
half of PrEP users reported discontinuation for reasons related
to the pandemic. PrEP users who discontinued PrEP commonly
reported temporary abstinence due to the pandemic, a desire to
save PrEP pills for use post-pandemic, or concerns about attending in-person health care to continue PrEP use. Continuing PrEP
users reported wanting to maintain the positive psychological
benefits of PrEP or wanting to keep up the habit.
These exploratory findings suggested preliminary patterns in
the use of two important aspects of preventative sexual health
care: birth control and PrEP. The discontinuation patterns in the
present study demonstrated key differences in how our healthcare system engages patients in birth control use and PrEP use.
Firstly, birth control is used to treat many medical needs beyond
pregnancy prevention, whereas the main use of PrEP is HIV
prevention. Many birth control users continued birth control even
when abstinent, citing health reasons. Secondly, birth control
users reported either using LARCs or having access to telemedicine or prescription delivery to continue birth control. In contrast,
several PrEP users reported challenges accessing health care.
While it is considered best medical practice for PrEP users to
receive quarterly STI testing (Centers for Disease Control & Prevention, 2017), requiring frequent interaction with the healthcare
system may be one barrier to sustained PrEP use, especially in
the context of a global pandemic.
PrEP users may also face more cultural stigma than birth control users at both the institutional and interpersonal levels. In
previous studies, cisgender men who have sex with men (MSM)
and transgender women who have sex with men have reported
anticipating or experiencing PrEP-related stigma from both
providers and potential sexual partners (Matacotta et al., 2020;
Schwartz & Grimm, 2016). Individuals in these groups, who
may already experience HIV stigma in the form of assumptions
about their sexual behavior and HIV risk (Earnshaw & Chaudoir,
2009), feared experiencing additional stigma if they used PrEP.
PrEP stigma in the healthcare system contributes to both limitations on PrEP access options (e.g., monitoring requirements, low
telehealth availability) and anticipated stigma for those seeking
PrEP care, making it harder for individuals to continue and manage PrEP treatment.
Individuals’ decisions about birth control versus PrEP continuation may have also been due to their own assumptions about
the potential outcomes of their sexual behavior. As previously
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stated, HIV risk is assumed to increase with the number of sexual partners (Centers for Disease Control & Prevention, 2017),
while pregnancy risk increases with each instance of intercourse,
regardless of the number of unique partners. More than twothirds of birth control users reported engaging in sexual activity since the beginning of the pandemic, and nearly as many
intended to do so in the next two weeks. However, only a small
subset of birth control users reported having sex with anyone
outside their household/lockdown pod (12.5%). This suggests
that birth control users who were sexually active during the first
months of the COVID-19 pandemic were predominately having
sex with relationship partners in their household. It is likely that
few participants discontinued birth control use in response to
the pandemic because the primary source of their unintended
pregnancy risk remained unchanged. Similarly, PrEP users may
have made decisions about continuation or discontinuation in
response to their understanding of their own sexual behavior.
Among those who reported having sex with someone outside
of their household or isolation pod, the vast majority indicated
intentions to remain on PrEP. Conversely, among those who were
not having sex with anyone outside of their household, more than
two-thirds discontinued PrEP or expressed intentions to do so.
This suggests that participants may have made decisions about
PrEP continuation in accordance with their expectation of having
new sexual partners during the pandemic.
Another consideration for understanding PrEP and birth
control use during COVID-19 is the difference in availability of
long-acting options. Many of the birth control users in our sample
used long-acting birth control methods, which facilitated birth
control continuation for some and posed particular issues for
others, such as those who needed to get their IUDs removed but
were unable to access in-person health care due to the pandemic.
Health information about the safety and efficacy of LARCs such
as the IUD should be available to support birth control users who
find themselves in this precarious position. Efforts to make sexual
health care available should also consider this need as there may
be certain clinicians who specialize in IUD insertion and removal
(Harper et al., 2012). The findings regarding long-acting birth
control have implications for future PrEP use, as the safety and
efficacy of long-acting injectable PrEP are currently being evaluated in clinical trials (Tolley et al., 2020). Because long-acting
PrEP will be administered in a shot and does not require removal,
long-acting PrEP has the potential to increase PrEP continuation
in general and especially in situations when there are additional
strains on the healthcare system, such as during the COVID19 pandemic or in rural areas with lesser healthcare resources
(Laditka et al., 2009).
A few participants reported saving their PrEP medication for
event-driven 2–1-1 dosing. This is notable because event-driven
PrEP is more appealing to individuals who can anticipate sexual
encounters (Reyniers et al., 2018) which may be more likely
during the COVID-19 pandemic, as individuals may be making more intentional decisions about close contact. Despite this,
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there is currently little health education about event-driven PrEP
(e.g., Saberi & Scott, 2020). Increasing awareness about effective event-driven PrEP use may facilitate successful biomedical
HIV prevention, especially in circumstances where preventative
sexual health care is especially limited.
Regarding birth control, several participants reported
increased vigilance around pregnancy prevention. In other
words, COVID-19 has made pregnancy especially undesirable
for some people. This is likely due to the additional financial,
health-related, and isolation-related challenges that would make
pregnancy and child-rearing particularly difficult (Dib et al.,
2020; Salehi et al., 2020). We did not see this pattern with PrEP
use. Individuals did not express increased vigilance over HIV
prevention. This may be related to decreased sexual behavior
associated with discontinuation; however, it may also be that HIV
and other illnesses may become less salient in a climate where
COVID-19 risk is centered in public health discourse (Stephenson et al., 2020).
In all, our findings point to the benefits of telemedicine and
prescription accessibility for facilitating preventative sexual
health care and that these benefits have not been extended to
PrEP to the same extent as birth control. The availability and use
patterns of hormonal birth control and PrEP in the present study
reflect larger cultural norms of prioritizing preventing unintended
pregnancy over sexually transmitted infections (World Health
Organization [WHO], 2017), particularly among single women,
and controlling the sexual behavior of populations stereotyped
as sexually promiscuous, such as sexual minority men (Pinsof &
Haselton, 2017). Especially during the healthcare disruptions of
the COVID-19 pandemic, it is crucial to increase remote accessibility of sexual health services and reduce the stigma associated
with their use.

Strengths and Limitations
There are several strengths and limitations to the present investigation. One strength is that this adds to the limited research on
PrEP and birth control use during COVID-19. Additionally, this
work has implications that extend beyond the time of the COVID19 pandemic and serve as a case study for thinking about barriers
and facilitators to PrEP and birth control as preventative sexual
health care. Utilizing a mixed-methods approach was informative
for understanding self-reported reasons for continuation and discontinuation. This approach allowed for the examination of general trends, as well as specific factors that affect decision making.
There are several limitations as well. First, this was an exploratory investigation of patterns of birth control and PrEP use using
an online convenience sample. Secondly, the sample sizes of
birth control discontinuers and PrEP users were too small for
inferential analyses. While the trends discussed are informative
for understanding use patterns, future studies should involve
larger, more representative samples and more complex statistical analyses.
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There are also limitations with some measures included in
the study. As previously stated, participants were asked, "Are
you currently using contraception/birth control methods other
than condoms (i.e., birth control pills, IUD, etc.)?” The question
did not specify contraception methods beyond those provided as
examples, and it was up to the interpretation of the participant
what exactly fell under the umbrella of “contraception” or “birth
control.” The survey contained display logic, such that only participants who indicated using contraception/birth control were
asked to select their birth control method from a provided list
created by the research team. The list included IUDs, hormonal
pills, injections, implants, and IUDs and hormonal pills together.
These options are only a limited set of possible contraception or
birth control options that participants could have been using, and
did not allow participants to indicate a method other than those
listed. However, 97.1% reported using one of the methods listed.
While it is possible that those using either permanent (e.g., tubal
sterilization, vasectomy) or less common birth control methods
(e.g., vaginal rings) were not included in the sample of birth control users, this does not appear to be the case. Four participants
self-identified as birth control users but skipped the following
question about their birth control method; two of these participants later described the use of permanent methods, suggesting
that those who used methods other than the ones listed likely
responded affirmatively to the question about birth control use
and then skipped the following question. Still, future research
should more explicitly and comprehensively define the category
of “birth control users.”
Further, although we did collect information demonstrating
that most participants were experiencing some type of lockdown
policy in their area of residence, we did not ask specifically about
whether healthcare facilities were open and available. Thus, we
cannot know for certain if those who reported continuing their
birth control or PrEP use did so due to easier access (e.g., doctor’s
offices still open at the time of survey completion) or due to their
own motivations. While the qualitative results speak to some of
these reasons, the present study does not fully contextualize each
respondent’s access in relation to pandemic constraints in one
particular place and time.
Another limitation is the discrepancy between the measures
of birth control use and continuation and the measures of PrEP
use and continuation. Both birth control users and PrEP users
were asked, “Do you have plans to discontinue your prescription during lockdown?” For both user groups, those who said
they had plans to discontinue were categorized as discontinuers.
However, for PrEP only, participants were also asked whether
they had already discontinued use during the pandemic, prior to
the time of the survey. Thus, for the comparison of PrEP users
and nonusers, PrEP discontinuers were people who either indicated that they had already stopped PrEP due to the pandemic or
indicated plans to discontinue soon. For the comparison of birth
control users and nonusers, birth control discontinuers were only
those who indicated plans to discontinue soon. The omission
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of the question regarding previous discontinuation among birth
control users during the pandemic but prior to the time of the
survey was an error on the part of the research team. As such, we
cannot know the percentage of our sample who had been on birth
control before but had already discontinued due to the pandemic.
The pandemic began in the USA around March 2020, and we
defined it for participants as such. The data collection period
ranged from April 2020 to June 2020. Thus, this leaves up to three
months unaccounted for. The majority of birth control users in
our sample (91.2%) did indicate continuing their birth control
use, and a review of the qualitative responses indicated that only
one birth control continuer had discontinued and reinitiated birth
control before the time of the survey. Thus, despite this difference
in measurement, it is unlikely that a sizeable number of those
categorized as birth control users would have discontinued their
birth control use due to the pandemic within that small window of
time prior to the survey. That said, any future research should certainly strive to capture discontinuation throughout the pandemic.
Further, because the question for PrEP users was worded as
whether or not they, “stopped due to lockdown orders,” it is possible that individuals who stopped for other reasons (e.g., something that decreased their risk level, like the beginning or end of a
relationship), may not have indicated discontinuation in response
to this question. Future research should examine these continuation and discontinuation patterns in more depth, including how
they were affected by specific aspects of pandemic health policy.
Although we examined similarities and differences between
continuation patterns and use of these two preventative medications, it is important to keep in mind that the groups utilizing
PrEP and birth control are demographically different. The individuals on birth control in our sample were primarily cisgender
women, while the individuals using PrEP were primarily sexual
minority men, consistent with overall use trends (Rodriguez
et al., 2020; Centers for Disease Control & Prevention, 2019).
Existing research suggests that women, in general, have higher
rates of healthcare utilization (Pinkhasov et al., 2010) and gender socialization may play a role in the differences in utilization
of these medications. Further, four individuals in our sample
reported concurrent birth control and PrEP use. These four individuals were white transgender men in their 20s who identified
as either gay or queer and utilized LARCs (i.e., either IUD or
implant). While not examined in depth in the present study, future
research should address patterns of simultaneous PrEP and birth
control use, with consideration of provider prescribing behaviors
that may target or leave out populations that could benefit from
access to this combination of services.
Notably, 10% (n = 13) of birth control users and 13% (n = 7)
of the PrEP users in the present study identified as transgender.
Due to the sample sizes of the birth control and PrEP continuers
and discontinuers, we were unable to examine meaningful differences between cisgender and transgender participants. However, existing research suggests that transgender individuals may
face particular barriers when accessing birth control (Harb et al.,
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2019) and PrEP (Sevelius et al., 2016), contingent upon systemic
inequities. It is imperative that future researchers strive to capture
the needs and experiences of transgender individuals to lessen
barriers to health care.
Additionally, the evaluation of sexual behavior in the present study is limited in that we did not examine survival sex or
sex work, which was likely heavily impacted during the pandemic (Platt et al., 2020). With half of the PrEP continuers in
our research sample (n = 14, 51.9%) having reported sex with
someone outside of their household/lockdown pod, there was
no opportunity for clarification as to if such sex outside of their
pod was required for income or other means of survival during
the pandemic (i.e., survival sex, sex in exchange for money, or
sex work). In bringing up this limitation of the study, we hope to
acknowledge that there are individuals whose sexual experiences
are not fully contextualized, especially considering the increase
of survival sex and sex work caused by financial challenges during the pandemic (Platt et al., 2020).

Future Research Directions
There are many future directions researchers should explore
related to birth control and PrEP use during and after the COVID19 pandemic. First, considering our sample was predominately
white, future research should focus specifically on access to preventative sexual health care among communities of color during the COVID-19 pandemic. This is especially important considering the ongoing impact of systemic racism on both sexual
health (Millett et al., 2020; Prather et al., 2016) and COVID-19
outcomes (e.g., Gravlee, 2020). In addition, as mentioned above,
more attention to the specific needs and challenges of transgender
and gender expansive individuals during the COVID-19 pandemic is warranted, both in relation to sexual health care and all
other aspects of care.
In addition, many participant responses discussed abstinence;
therefore, it is important to continue to examine how sexual
behavior patterns relating to birth control and PrEP use change
over the course of the pandemic. This is especially important
as there will likely be regions around the world engaging in
COVID-19 precautions for a long time, and it is unclear how
people will behave in times of prolonged viral threat. Will individuals return to engaging in higher levels of sexual behavior,
even when COVID-19 is still an imminent risk? How will these
behavioral shifts contribute to preventative sexual healthcare
needs? Researchers should also examine patterns of re-uptake
of PrEP among individuals who stopped use during the pandemic. Is it harder for individuals who have discontinued to then
re-uptake PrEP and maintain adherence when sexual health care
becomes more accessible? Have PrEP discontinuers made plans
to restart PrEP? Further, how has COVID-19 influenced attitudes
toward HIV prevention and pregnancy overall? A recent study
demonstrated that gay and bisexual men engaged in more precautionary behavior than did heterosexual men in response to
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the COVID-19 pandemic (Price, Gesselman, et al., 2020). The
researchers proposed that as gay and bisexual men have been the
target of HIV-reduction campaigns for decades, these men likely
better understand why precautionary behavior is necessary and
beneficial. As the COVID-19 pandemic further centers conversations on contagion, self-protection, and consideration of the
well-being of others, we may see changing cognitions around
HIV and HIV prevention. Our own results suggest an increased
vigilance over pregnancy prevention among birth control users,
but research directly examining these patterns over time will contribute to a more complete understanding of reasons for engagement in—and barriers to—preventative sexual health care.
Additionally, future research should examine the structuraland policy-related factors that impact sexual health care during
the pandemic. How do different COVID-19 safety policies and
healthcare structures impact preventative sexual health care differently? Are there contexts we can look to as a model for accessible sexual health care during the pandemic, and how can we
have procedures in place in the case of future challenges? Understanding the systems themselves is important for understanding
the contexts in which people are making decisions about birth
control and PrEP use.
This research on birth control and PrEP use in the context of
the COVID-19 pandemic is ongoing. We are currently administering a follow-up survey to examine how participants’ sexual
behavior and utilization of sexual healthcare services changed
over the first year of the COVID-19 pandemic. We thereby hope
to address many of the questions posed by the current study.
Additionally, we will explore how state-level lockdown policies
and rates of COVID-19 transmission impacted preventative
sexual healthcare access and utilization. At the time of the initial
survey creation, it was not yet clear how COVID-19 rates and
related restrictions would fluctuate in the subsequent months, and
to what extent these patterns would be region-specific. By asking
participants follow-up questions about their local environment,
we will be able to further contextualize their experiences with
preventative sexual health care in the context of the COVID-19
pandemic.

Conclusion
In the USA, the COVID-19 pandemic has created challenges for
many domains within the healthcare sector, including preventative sexual health care. If access to, and continuation of, preventative sexual health care—such as birth control or PrEP use—has
been interrupted or threatened due to the COVID-19 pandemic,
we may observe those negative effects at the national level for
years to come (e.g., higher rates of unintended pregnancies and
new cases of HIV). In this study, most participants reported continuation of their hormonal birth control along with increased
vigilance over pregnancy prevention. Conversely, around half
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of PrEP-using participants reported already discontinuing or
planning to discontinue their PrEP regimen. Many cited current
abstinence and desire to “stockpile” for a time when they will
be sexually active again. Both of these patterns of findings have
implications for future research and intervention design.
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